![Scott Byrd](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Byrd
Chairman at
ACACIA PHARMA GROUP PLC
Profile
Scott A. Byrd is Chief Executive Officer & Director at Sudo Biosciences, Inc. since 2021.
Mr. Byrd is Independent Chairman at Acacia Pharma Group Ltd. since 2015.
Mr. Byrd is Non-Executive Director at Acacia Pharma Ltd. Mr. Byrd is Independent Director at AlgoTherapeutix SAS. Formerly, Mr. Byrd was President, CEO, Secretary & Treasurer at Outpost Medicine, Inc. Mr. Byrd was President & Chief Executive Officer at Outpost Medicine Ltd. from 2017 to 2023.
Mr. Byrd was Senior Director-Global Brands at Eli Lilly & Co. from 1992 to 2006.
Mr. Byrd was Chief Commercial Officer & Senior Vice President at Mallinckrodt Hospital Products, Inc. from 2009 to 2014.
Mr. Byrd was President & Chief Operating Officer at Acacia Pharma, Inc. from 2009 to 2014.
Education includes undergraduate degree from Bradley University and MBA from Harvard Business School.
Scott Byrd active positions
| Companies | Position | Start |
|---|---|---|
| ACACIA PHARMA GROUP PLC | Chairman | 2020-03-01 |
Acacia Pharma Ltd.
 Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Provides supportive care product opportunities for post-surgical and cancer patients | Director/Board Member | - |
Algotherapeutix SAS
 Algotherapeutix SAS Medical SpecialtiesHealth Technology Manufactures clinical supplies | Director/Board Member | - |
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Chief Executive Officer | 2021-03-31 |
Former positions of Scott Byrd
| Companies | Position | End |
|---|---|---|
Outpost Medicine Ltd.
 Outpost Medicine Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chief Executive Officer | 2023-09-04 |
| CADENCE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2014-03-18 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Outpost Medicine, Inc.
 Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in drug development activities | Chief Executive Officer | - |
Acacia Pharma, Inc.
 Acacia Pharma, Inc. Medical DistributorsDistribution Services Distributes pharmaceutical products | President | 2013-12-31 |
Training of Scott Byrd
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Bradley University
 Bradley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Acacia Pharma Ltd.
Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Provides supportive care product opportunities for post-surgical and cancer patients | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acacia Pharma Group Ltd.
 Acacia Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that engages in developing and commercializing novel products for surgery, invasive procedures & chemotherapy | Health Technology |
Acacia Pharma, Inc.
Acacia Pharma, Inc. Medical DistributorsDistribution Services Distributes pharmaceutical products | Distribution Services |
Outpost Medicine, Inc.
Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in drug development activities | Health Technology |
Outpost Medicine Ltd.
Outpost Medicine Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology Manufactures clinical supplies | Health Technology |
Sudo Biosciences, Inc.
Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Health Technology |
- Stock Market
- Insiders
- Scott Byrd
